Hameln
Germany
2
2020-04-30
2
2020-11-24
These are the the leading inventors for applications assigned to Hameln Pharma Plus GmbH:
Hameln Pharma Plus GmbH based in Hameln, DE has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Intermediates for the preparation of remifentanil hydrochloride
#2 | 2016-05-12 ✅ Patent 9,447,120 granted on 2016-09-20Crystalline forms of zinc trisodium pentetic acid
Also check out Hameln Pharma Plus GmbH's (Hameln, Germany) applicant profile with 2 patent applications submitted.
157614 ⎘